Table 4. Summary of adverse events during 24 weeks.

Author	Percentage of any adverse events (%)
	Placebo	Dose: 150 µg/d	Dose: 300 µg/d	Dose: 450 µg/d
Braunstein G. et al. [1]	72.9	-	79.0	-
Davis S. et al. [2]	87.7	84.3	87.6	-
Panay N. et al. [3]	71.1	-	62.3	-
Shifren J. et al. [4]	71.0	77.0	76.0	75.0
Simon J. et al. [5]	79.6	-	77.7	-